| Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939) |
|---|
| 01/23/2003 | US20030018196 Piperidine derivatives and process for their production |
| 01/23/2003 | US20030018193 Beta-alanine derivatives and their use as receptor anatgonists |
| 01/23/2003 | US20030018080 N-methoxymethyl-5,5-diphenylbarbituric acid |
| 01/23/2003 | US20030018070 Bisaryl compound and medicament for cancer treatment comprising the same |
| 01/23/2003 | US20030018059 Antiinflammatory agents; antihistamines; antiallergens |
| 01/23/2003 | US20030018048 Antidepressants; psychological disorders; Parkinson's disease |
| 01/23/2003 | US20030018045 Heterocyclic beta-3 adrenergic receptor agonists |
| 01/23/2003 | CA2453503A1 N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds |
| 01/23/2003 | CA2453169A1 Substituted amides, sulfonamides and ureas useful for inhibiting kinase activity |
| 01/23/2003 | CA2418173A1 N-substituted-1-amino-1,1-dialkylcarboxylic acid derivatives |
| 01/22/2003 | EP1277737A1 Diphenylalkylamine derivatives useful as opioid delta receptor agonists |
| 01/22/2003 | EP1277729A1 Ppar (gamma) modulators |
| 01/22/2003 | EP1276741A1 Phenyl substituted 4-hydroxy tetrahydropyridone |
| 01/22/2003 | EP1276480A1 Process of making racemic bupivacaine's enantiomers, levobupivacaine's pharmaceutical compositions, levobupivacaine's pharmaceutical compositions formulated on its free base form or its pharmaceutical acceptable salts and use of levobupivacaine's pharmaceutical compositions formulated on its free ba |
| 01/22/2003 | EP0646115B1 Heterocyclic-cyclic amine derivatives |
| 01/22/2003 | CN1099425C 新的肽衍生物 New peptide derivatives |
| 01/22/2003 | CN1099416C Integrin receptor antagonisis |
| 01/21/2003 | US6509494 Distillation mixture of dicyclopentenyl esters |
| 01/21/2003 | US6509464 1-Heteroaryl-pyrrolidine, piperidine, or homopiperidine derivates; nervous system disorder treatment; amidation |
| 01/21/2003 | US6509358 For therapy of metabolic disorders related to insulin resistance or hyperglycemia, typically associated with obesity or glucose intolerance), atherosclerosis, gastrointestinal disorders, neurogenic inflammation, glaucoma |
| 01/21/2003 | US6509356 1-(4-(Substituted alkoxy)benzyl)naphthalene compounds having estrogen inhibitory activity |
| 01/21/2003 | US6509355 Treatment of disorders of the outer retina |
| 01/21/2003 | US6509354 3-arylphenyl sulfide derivative and insecticide and miticide |
| 01/21/2003 | US6509346 Chemokine receptor antagonists and methods of use therefor |
| 01/21/2003 | US6509339 Gastrointestinal disorders; cardiovascular disorders |
| 01/21/2003 | US6509337 A method of treating a mammalian disease condition mediated by metalloproteinase activity which comprises administering to a mammal in need thereof a therapeutically effective amount of a compound as defined in claim 1 or a pharmaceutically |
| 01/21/2003 | US6509309 Cleaning composition comprising alkoxy substituted perfluoro compounds |
| 01/21/2003 | US6509003 N-alkylpiperidine derivatives labeled with radioactive iodine; use in single photon emission computed tomography (SPECT) |
| 01/17/2003 | WO2002006269A1 Cyclic amino acid derivatives |
| 01/17/2003 | CA2415964A1 Cyclic amino acid derivatives |
| 01/16/2003 | WO2003004487A1 Piperidine derivatives useful as modulators of chemokine receptor activity |
| 01/16/2003 | WO2003004472A1 Arylamines for the treatment of conditions associated with gsk-3 |
| 01/16/2003 | WO2003004471A1 Multifunctional alkoxyamines based on polyalkylpiperidines, polyalkylpiperazinones and polyalkylmorpholinones and their use as polymerization regulators/initiators |
| 01/16/2003 | WO2003004027A1 Substituted anilinic piperidines as mch selective antagonists |
| 01/16/2003 | WO2003004026A1 Substituted 1-phenethylpiperidine compounds used as inter alia analgesics |
| 01/16/2003 | WO2003004025A1 High purity amlodipine benzenesulfonate and a process for its preparation |
| 01/16/2003 | US20030013847 Pyruvate derivatives |
| 01/16/2003 | US20030013846 Cytoprotective agents |
| 01/16/2003 | US20030013757 Aromatic dicarboxylic acid derivatives |
| 01/16/2003 | US20030013741 Antihistamines; antiallergens |
| 01/16/2003 | US20030013725 Amino acid derivatives |
| 01/16/2003 | US20030013723 Novel urokinase inhibitors |
| 01/16/2003 | US20030013721 Antiinflammatory agents; immunology; cardiovascular disorders; rheumatic disorders |
| 01/16/2003 | US20030013720 Antidiabetic agents; obesity |
| 01/16/2003 | US20030013714 Sleep disorders; eating disorders; sexual disorders; hypotensive agents |
| 01/16/2003 | US20030013657 Reducing oxidation stresses; central nervous system disorders; antiinflammatory agents |
| 01/16/2003 | US20030013656 Reducing oxidation stresses; central nervous system disorders; antiinflammatory agents |
| 01/16/2003 | CA2454613A1 Substituted anilinic piperidines as mch selective antagonists |
| 01/16/2003 | CA2452686A1 Arylamines for the treatment of conditions associated with gsk-3 |
| 01/16/2003 | CA2452597A1 Piperidine derivatives useful as modulators of chemokine receptor activity |
| 01/16/2003 | CA2450232A1 Multifunctional alkoxyamines based on polyalkylpiperidines, polyalkylpiperazinones and polyalkylmorpholinones and their use as polymerization regulators/initiators |
| 01/15/2003 | EP1275645A1 Labeled compounds for measuring the function of the muscarinic acetylcholine nervous system |
| 01/15/2003 | EP1275644A1 Benzenesulfonamide derivatives, process for their preparation and pharmaceutical compositions containing them |
| 01/15/2003 | EP1275641A2 Benzenesulfonamide derivatives, process for their preparation and pharmaceutical compositions containing them |
| 01/15/2003 | EP1274701A1 Chemical compounds |
| 01/15/2003 | EP1274457A2 Method and compositions for the treatment of allergic conditions using pgd2 receptor antagonists |
| 01/15/2003 | EP1274430A2 Compounds for treating fibromyalgia and chronic fatigue syndrome |
| 01/15/2003 | EP1274411A1 Phenylethylamines and condensed rings variants as prodrugs of catecholamines, and their use |
| 01/15/2003 | EP0989120B1 Reagents for assaying central local acetylcholinesterase activity |
| 01/15/2003 | EP0820451B1 Novel heterocyclic compounds |
| 01/15/2003 | EP0729468B1 Non-peptide tachykinin receptor antagonists |
| 01/15/2003 | EP0659078B1 Anabaseine derivatives useful in the treatment of degenerative diseases of the nervous system |
| 01/15/2003 | EP0649412B1 Pharmaceutical pyridine compounds |
| 01/15/2003 | CN1391565A Benzophenones as inhibitors of reverse transcriptase |
| 01/15/2003 | CN1391473A VLA-4 inhibitor compounds |
| 01/15/2003 | CN1391469A Npyy5拮抗剂 Npyy5 antagonist |
| 01/15/2003 | CN1098838C Substituted N-(indole-2-carbonyl)-beta-alanimamides and derivatives as antidiabetic agents |
| 01/14/2003 | US6506901 1-(9H-Carbazol-4-yloxy)-3-((1-(7-trifluoromethyl-quinolin-4-yl) -piperidin-4-lmethyl)-amino)-propan-2-ol, for example; treating diabetes, urinary continence, atherosclerosis, gastrointestinal disorders, glaucoma |
| 01/14/2003 | US6506876 LTA4 hydrolase inhibitor pharmaceutical compositions and methods of use |
| 01/14/2003 | US6506788 N-linked urea or carbamate of heterocyclic thioesters for vision and memory disorders |
| 01/14/2003 | US6506777 Method for modulation of CCR-3 or CCR-5 chemokine receptor activity in a mammal in need thereof to treat asthma, allergic rhinitis, dermatitis, conjunctivitis, atherosclerosis or rheumatoid arthritis, which comprises the administration of an |
| 01/14/2003 | US6506775 Substituted benzylaminopiperidine compounds |
| 01/14/2003 | US6506764 Hydroxamic and carboxylic acid derivatives |
| 01/14/2003 | US6506759 Retroviral protease inhibitors |
| 01/14/2003 | US6506701 Polymer-supported quenching reagent covalently reacts with unreacted starting materials |
| 01/14/2003 | US6506580 Splice variants for human 5-HT4 serotonin receptor and their applications, in particular for screening |
| 01/14/2003 | US6506459 Coating compositions containing alkoxy substituted perfluoro compounds |
| 01/14/2003 | CA2217477C Tricyclic compounds useful for inhibition of farnesyl protein transferase |
| 01/09/2003 | WO2003002534A1 Bis-piperidines |
| 01/09/2003 | WO2002022579A3 Antipsychotic sulfonamide-heterocycles, and methods of use thereof |
| 01/09/2003 | US20030008901 For therapy of arthritis, cancer, and other diseases characterized by matrix metalloproteinase or mammalian reprolysin activity |
| 01/09/2003 | US20030008900 Compounds and compositions for delivering active agents |
| 01/09/2003 | US20030008888 Novel cyano-substituted dihydropyrimidine compounds and their use to treat diseases |
| 01/09/2003 | US20030008881 Substituted phenylcyclohexanecarboxamides and their use |
| 01/08/2003 | EP1273572A1 Thiophene substituted piperazines useful in the treatment of benign prostatic hyperplasia |
| 01/08/2003 | EP1272456A1 Hydrazide and alkoxyamide angiogenesis inhibitors |
| 01/08/2003 | EP1272175A2 Il-8 receptor antagonists |
| 01/08/2003 | EP1119355B1 Naphthalenecarboxamides as tachykinin receptor antagonists |
| 01/08/2003 | EP1098651B1 Novel urokinase inhibitors |
| 01/08/2003 | CN1390201A Cyclic amine compounds as CCR5-antagonists |
| 01/08/2003 | CN1390200A Inhibitors of metalloproteinases |
| 01/08/2003 | CN1390193A Novel dicarboxylic acid derivatives with pharmaceutical properties |
| 01/08/2003 | CN1098263C Pyridin-2-yl-methylaminederivatives, method of preparing and application as medicine |
| 01/07/2003 | US6503949 Glucagon antagonists/inverse agonists |
| 01/07/2003 | US6503928 Central nervous system disorders; psychological disorders |
| 01/07/2003 | US6503905 3,3-biarylpiperidine and 2,2-biarylmorpholine derivatives |
| 01/07/2003 | US6503898 Administering 4,7-dibenzyl-5,6-dihydroxy-N,N*-di(m-aminobenzyl)--1,3-diazepin-2-one or salt to treat human immunodeficiency virus infection |
| 01/07/2003 | US6503897 N-Formylhydroxylamine derivatives; veterinary medicine; grampositive and gramnegative bacteria |
| 01/07/2003 | CA2075684C 1-acylpiperidine compounds |
| 01/03/2003 | WO2003000658A1 PROCESS FOR THE PREPARATION OF A HIGHLY PURE PHARMACEUTICAL INTERMEDIATE, 4-(CYCLOPROPYLCARBONYL)-α,α-DIMETHYLPHENYLACETIC ACID |